In Malaysia，Chinese medicine is under the domain of traditional and complementary medicine(T&CM).Ministry of Health in Malaysia officially launched Traditional and Complementary Medicine Blueprint 2018—2027(Healthcare)on 13th March 2018，referred to as the blueprint of Chinese medicine in this paper.It is an opportunity for this paper to systematically introduce and review parts of the blueprint dealing with Chinese medicine from a macro perspective，including the purpose，content and main achievements of the blueprint，and share challenges confronted by the industry of Chinese medicine nowadays and medium-term and long-term strategic responses mentioned in the blueprint.There are 3 major achievements in this blueprint.Firstly，it outlines macroscopic framework of Chinese medicine development in Malaysia.In Malaysian traditional medicine，there are 2 special national conditions leading to 4 unique features that take diversity as the root.Secondly，from 4 major microscopic directions：clinical practice，education，scientific research and medicinal supervision and regulation，the blueprint illustrates microscopic status of Chinese medicine.It explores the challenges confronted by the industry of Chinese medicine and induced by unclear developmental direction and insufficient resource investment，as well as their causes and consequences.Thirdly，the blueprint clearly specifies the developmental direction in the coming 10 years.The mentioned 6 major policies fully reflect that the blueprint is based on the developmental rules of Chinese medicine.They creatively put forward 3 core concepts of strengthening appropriateness of various policies，optimizing resource investment and moving towards professionalism.The formulation，implementation and supervision of the blueprint are basically in accordance with Malaysian core values of teamwork，collective consultation and building consensus.